This post-marketing surveillance study is designed to supplement the data on efficacy and tolerability of Micardis® and MicardisPlus® in patients at cardiovascular risk under general practice conditions. The aim of the study is to investigate the effect of a six-month treatment with Micardis® / MicardisPlus® on blood pressure and the effect of the Lifestyle education tool for weight reduction on blood pressure control. In addition, the post-marketing surveillance study will provide information on the effects on target measurement of the Lifestyle education tool and various laboratory parameters produced by treatment with Micardis® and MicardisPlus® in an unselected patient population under general practice conditions.
Study Type
OBSERVATIONAL
Enrollment
1,856
Boehringer Ingelheim Investigational Site 34
?adca, Slovenia
Boehringer Ingelheim Investigational Site 2
Banská Bystrica, Slovenia
Boehringer Ingelheim Investigational Site 3
Banská Bystrica, Slovenia
Boehringer Ingelheim Investigational Site 4
Banská Bystrica, Slovenia
Boehringer Ingelheim Investigational Site 5
Banská Bystrica, Slovenia
Boehringer Ingelheim Investigational Site 6
Banská Bystrica, Slovenia
Boehringer Ingelheim Investigational Site 7
Banská Bystrica, Slovenia
Boehringer Ingelheim Investigational Site 8
Banská Bystrica, Slovenia
Boehringer Ingelheim Investigational Site 10
Bardejov, Slovenia
Boehringer Ingelheim Investigational Site 11
Bardejov, Slovenia
...and 172 more locations
Changes in Mean Blood Pressure (Systolic) After Treatment, Compared to Baseline
Changes in blood pressure in patients with systolic values, measured at baseline and final visit, by treatment and by Tool/No Tool
Time frame: 24 weeks (Visit 1 to Visit 3)
Changes in Mean Blood Pressure (Diastolic) After Treatment, Compared to Baseline
Changes in blood pressure in patients with diastolic values, measured at baseline and final visit, by treatment and by Tool/No Tool
Time frame: 24 weeks (Visit 1 to Visit 3)
Changes in Laboratory Parameters:Low Density Lipoprotein (LDL)
Changes in LDL cholesterol levels from baseline to final visit in patients with both laboratory values valid, by treatment and by Tool/No Tool
Time frame: 24 weeks (Visit 1 to Visit 3)
Changes in Laboratory Parameters:High Density Lipoprotein (HDL)
Changes in LDL cholesterol levels from baseline to final visit in patients with both laboratory values valid, by treatment and by Tool/No Tool
Time frame: 24 weeks (Visit 1 to Visit 3)
Changes in Laboratory Parameters: Triglycerides
Changes in the triglyceride levels from baseline to final visit in patients with both laboratory values valid, by treatment and by Tool/No Tool
Time frame: 24 weeks (Visit 1 to Visit 3)
Changes in Laboratory Parameters: Blood Glucose
Changes in the fasting blood glucose levels from baseline to final visit in patients with both laboratory values valid, by treatment and by Tool/No Tool
Time frame: 24 weeks (Visit 1 to Visit 3)
Assessment of Metabolic Effect
Metabolic effect was rated by the investigators as 'positive', 'neutral' and 'negative'
Time frame: 24 weeks (Visit 1 to Visit 3)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.